Congratulations to Lunarsun Pharmaceuticals on the public announcement of their new active pharmaceutical ingredients, oseltamivir and everalen!

News Center / Company news

2022.03.29

In March 2022, congratulations to Lairuisen Pharmaceuticals on successfully passing the evaluation and activating the registration status "A" for the import declaration of raw materials oseltamivir and efaviren. Welcome to cooperate.

Prev：Welcome to Wuhan API Exhibition!

Return

Great News | Imported API Furosemide Receives NMPA Marketing Approval

2026.07.21

NMPA-Approved Vonoprazan Fumarate Tablets – Seeking Global Partners

2026.07.10

Congratulations to Chongqing Saintsun Pharmaceutical Co., Ltd. on Obtaining the Drug Registration Certificate for its developed product, Sodium Thiosulfate Injection

2026.07.02

About us

Generics For Domestic

APIs and intermediates for domestic market

Products for Export

News